Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor

Publisher： Karger

E-ISSN： 1662-6575|5|3|622-626

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.3, 2012-11, pp. : 622-626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete Pathological Remission of Locally Advanced, Unresectable Pancreatic Cancer (LAPC) after Intensified Neoadjuvant Chemotherapy

By  

Oncology Research and Treatment, Vol. 36, Iss. 3, 2013-02 ,pp. : 123-125

Karger

Access to resources Recommend Favorite

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 648-655

Karger

Access to resources Recommend Favorite

Cytotoxic chemotherapy for pancreatic neuroendocrine tumors

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 628-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 623-627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co-Existent Chronic Pancreatitis and Pancreatic Neuroendocrine Tumor

By  

Pancreatology, Vol. 1, Iss. 2, 2001-05 ,pp. : 117-122

Karger

Access to resources Recommend Favorite